Welgene Biotech Co.,Ltd. (6661.TWO)

TWD 19.7

(2.6%)

Gross Profit Summary of Welgene Biotech Co.,Ltd.

Welgene Biotech Co.,Ltd.'s latest annual gross profit in 2023 was 119.71 Million TWD , down -15.58% from previous year.
Welgene Biotech Co.,Ltd.'s latest quarterly gross profit in 2024 Q2 was 25.17 Million TWD , up 18.61% from previous quarter.
Welgene Biotech Co.,Ltd. reported a annual gross profit of 141.8 Million TWD in annual gross profit 2022, up 6.41% from previous year.
Welgene Biotech Co.,Ltd. reported a annual gross profit of 133.26 Million TWD in annual gross profit 2021, down -17.89% from previous year.
Welgene Biotech Co.,Ltd. reported a quarterly gross profit of 26.55 Million TWD for 2024 Q1, down -7.81% from previous quarter.
Welgene Biotech Co.,Ltd. reported a quarterly gross profit of 28.8 Million TWD for 2023 Q4, down -13.93% from previous quarter.

Annual Gross Profit Chart of Welgene Biotech Co.,Ltd. (2023 - 2014)

Historical Annual Gross Profit of Welgene Biotech Co.,Ltd. (2023 - 2014)

Year	Gross Profit	Gross Profit Growth
2023	119.71 Million TWD	-15.58%
2022	141.8 Million TWD	6.41%
2021	133.26 Million TWD	-17.89%
2020	162.29 Million TWD	-7.02%
2019	174.54 Million TWD	-2.04%
2018	178.17 Million TWD	21.81%
2017	146.26 Million TWD	14.55%
2016	127.68 Million TWD	-4.16%
2015	133.22 Million TWD	13.53%
2014	117.34 Million TWD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	25.17 Million TWD	18.61%
2024 Q1	26.55 Million TWD	-7.81%
2023 Q4	28.8 Million TWD	-13.93%
2023 FY	119.71 Million TWD	-15.58%
2023 Q1	21.45 Million TWD	-25.76%
2023 Q2	35.97 Million TWD	67.67%
2023 Q3	33.47 Million TWD	-6.97%
2022 Q2	48.91 Million TWD	61.21%
2022 Q4	28.9 Million TWD	-14.07%
2022 Q3	33.63 Million TWD	-31.24%
2022 Q1	30.34 Million TWD	-37.0%
2022 FY	141.8 Million TWD	6.41%
2021 Q3	31.68 Million TWD	-1.71%
2021 FY	133.26 Million TWD	-17.89%
2021 Q4	48.16 Million TWD	52.03%
2021 Q1	21.18 Million TWD	-53.22%
2021 Q2	32.23 Million TWD	52.18%
2020 FY	162.29 Million TWD	-7.02%
2020 Q4	45.27 Million TWD	5.31%
2020 Q3	42.99 Million TWD	9.62%
2020 Q2	39.21 Million TWD	12.67%
2020 Q1	34.8 Million TWD	-39.56%
2019 FY	174.54 Million TWD	-2.04%
2019 Q4	57.59 Million TWD	16.52%
2019 Q3	49.42 Million TWD	46.4%
2019 Q2	33.76 Million TWD	0.0%
2019 Q1	33.76 Million TWD	-36.23%
2018 Q2	36.14 Million TWD	0.0%
2018 FY	178.17 Million TWD	21.81%
2018 Q1	36.14 Million TWD	-14.48%
2018 Q3	52.93 Million TWD	46.46%
2018 Q4	52.93 Million TWD	0.0%
2017 Q3	42.26 Million TWD	36.94%
2017 Q2	30.86 Million TWD	0.0%
2017 Q4	42.26 Million TWD	0.0%
2017 FY	146.26 Million TWD	14.55%
2017 Q1	30.86 Million TWD	-14.59%
2016 FY	127.68 Million TWD	-4.16%
2016 Q4	36.13 Million TWD	0.0%
2016 Q3	36.13 Million TWD	30.42%
2016 Q2	27.7 Million TWD	0.0%
2016 Q1	27.7 Million TWD	0.0%
2015 FY	133.22 Million TWD	13.53%
2014 FY	117.34 Million TWD	0.0%

Peer Gross Profit Comparison of Welgene Biotech Co.,Ltd.

Name	Gross Profit	Gross Profit Difference
BIONET Corp.	638.27 Million TWD	81.244%
DIVA Laboratories, Ltd.	250.77 Million TWD	52.261%
Genetics Generation Advancement Corp.	236.83 Million TWD	49.451%
Puriblood Medical Co., Ltd.	6.52 Million TWD	-1735.291%
TFBS Bioscience Inc.	77.82 Million TWD	-53.819%